FIELD: medicine.
SUBSTANCE: method includes increase of biomass of human germ stem cells of non-feeder line hESKM-05 with application of main medium mTeSR in flasks covered with matrigel. After that, performed is subcultivation by means of 0.05% dispase solution. Then, in order to form germ stem cells of embrioid bodies, by means of dispase cells are transferred into "коДМЕМ" medium with addition of 10% substituent of SR serum, 100 mcg/ml of sulfate canamicine, 1mM of L-glutamine solution and 1 mM solution of essential amino acids, as well as 2 mcg/ml solution of 5-asa-2-seoxycitidine or 2 mcM of sodium butirate solution and stimulated for 3 days. After that retransmission onto prepared collagen-chitosane matrix and cultivation in nutritional medium "коДМЕМ" with addition of 1 mM solution of essential amino acids, 1 mM of L-glutamine, 10% substituent of SR serum, 10-7 M of retinoic acid and 10 ng/ml of ascorbic acid are performed with replacement of solution every three days.
EFFECT: invention makes it possible to obtain cardiomyicytal matrix suitable for direct transplantation.
7 dwg, 1 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR PRODUCING NEURONAL MATRIX | 2010 | 
 | RU2431666C1 | 
| METHOD OF PREPARING SKIN CELL MATRIX | 2008 | 
 | RU2391399C2 | 
| METHOD FOR IN VITRO SLOW DOWN OF INITIAL STAGES OF DIFFERENTIATING EMBRYONIC STEM CELLS OF MAMMALS EXCEPT PRIMATES | 2009 | 
 | RU2396341C1 | 
| METHOD FOR OBTAINING ENDOTHELIOCYTES FROM HUMAN EMBRYONIC STEM CELLS (VERSIONS) | 2008 | 
 | RU2359030C1 | 
| METHOD FOR OBTAINING AND APPLICATION OF TISSUE ENGINEERING STRUCTURES BASED ON PROGENITAL CELLS FOR HEART DISEASES TREATMENT | 2015 | 
 | RU2636464C2 | 
| METHOD OF SPINAL TISSUE ENGINEERING FOLLOWING ANATOMICAL RUPTURE | 2012 | 
 | RU2489176C1 | 
| METHOD FOR PRODUCING PROGENITOR CELLS OF MYOCARDIUM | 2013 | 
 | RU2542964C1 | 
| METHOD OF PRODUCING MAMMAL EMBRYONIC STEM CELLS MODIFIED WITH HUMAN NERVE GROWTH FACTOR GENE | 2011 | 
 | RU2458984C1 | 
| METHOD OF CONSTRUCTING MASS OF MYOCARDIAL CELLS AND USE OF MASS OF MYOCARDIAL CELLS | 2008 | 
 | RU2467066C2 | 
| METHOD OF OBTAINING OF PATIENT (DONOR) - SPECIFIC FIBROBLAST-LIKE CELLS FROM INDUCED PLURIPOTENT HUMAN STEM CELLS | 2014 | 
 | RU2568059C1 | 
Authors
Dates
2011-09-27—Published
2010-04-12—Filed